• PHP45 Predictability of Pharmaceutical Spending Using Clinical Risk Groups in the Valencian Community in Valencia

    Nov 1, 2011, 00:00

  • PCN120 The Natural History of Fludarabine-Refractory Chronic Lymphocytic Leukemia Patients Who Fail Alemtuzumab or Have Bulky Lymphadenopathy – A European Perspective

    Nov 1, 2011, 00:00

  • PHP14 Multiple Indication Pricing, Reimbursement and Funding Dynamics- The Case of Orphan Indications

    Nov 1, 2011, 00:00

  • PCN192 BIA Results Could Stop Introduction of Cost-Effectiveness Therapy into Standard Treatment - Example from Croatia

    Nov 1, 2011, 00:00

  • PIH44 Health-Related Quality of Life for Patients with Chronic Conditions- Revealing the Profile of Burden Associated with Co-Morbid Physical and Mental Conditions in Respondents from Five European Countries

    Nov 1, 2011, 00:00

  • PCN9 Adverse Events Among Patients with Metastatic Colorectal Cancer Treated with Monoclonal antibodies in Clinical Practice

    Nov 1, 2011, 00:00

  • PSY40 Eq-5D Utilities in Patients with Chronic Pain Due to Osteoarthritis of the Knee or Low Back Pain Treated with Tapentadol and Oxycodone

    Nov 1, 2011, 00:00

  • PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special Populations

    Nov 1, 2011, 00:00

  • PSS46 Availability of Resources for Patients With Wet Age-Related Macular Degeneration- Optimal Study

    Nov 1, 2011, 00:00

  • PSS4 Longer Term Patient Benefits of Polyquad® Preservative Instead of Benzalkonium Chloride in Prostaglandin Eye Drops- A Microsimulation Model in Ocular Hypertension and Open-Angle Glaucoma

    Nov 1, 2011, 00:00

  • PIN10 Clinical and Economic Burden of Hospital Onset Health Care Facility Acquired Clostridium Difficile Infection (HO-HCFA-CDI) in Europe- A Systematic Review

    Nov 1, 2011, 00:00

  • PRM35 Agreement Between Patients' Self-Report and Physicians' Prescriptions on Drugs and Vaccine Exposure- The International PGRX Database Experience

    Nov 1, 2011, 00:00

  • PSY25 What is the Economic Impact of Obesity on Hospital Inpatient Care?

    Nov 1, 2011, 00:00

  • PMD75 Patient Self-Testing of Oral Anticoagulation Therapy by CoaguChek® XS System. Rapid Health Technology Assessment in Slovak Health Care Environment

    Nov 1, 2011, 00:00

  • PIN32 Economic Burden of Non-CF Bronchiectasis Enrolled in a US Managed Care Plan

    Nov 1, 2011, 00:00

  • PSY30 Cost Effectiveness of Tramadol Versus Diclophenac in Pain Management After Cesarean Delivery

    Nov 1, 2011, 00:00

  • PCV26 Real World Add-On and Switch Patterns for Platelet Aggregation Inhibitors

    Nov 1, 2011, 00:00

  • PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in Thailand

    Nov 1, 2011, 00:00

  • PIH62 Comparative Pricing and Reimbursement Analysis in Four East European Countries

    Nov 1, 2011, 00:00

  • PIN17 Modelling Budget Impact (BI) of Vaccinating At-Risk Adults and the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Germany

    Nov 1, 2011, 00:00

  • PIH9 Follow Up Balance and Gait Examination During Pregnancy

    Nov 1, 2011, 00:00

  • PMD42 Cost-Effectiveness of Using the UGT1A1 Pharmacogenetic Test to Reduce the Incidence of Irinotecan Chemotherapy-related Febrile Neutropaenia

    Nov 1, 2011, 00:00

  • PHP34 Necesidades De información Y formación Sobre Farmacoeconomia E Investigación De Resultados Para Profesionales Y Estudiantes De Farmacia Del Oriente Venezolano

    Nov 1, 2011, 00:00

  • PCV69 Economic Evaluation of Primary Prevention of Cardiovascular Diseases in Mild Hypertension- A Scenario Analysis for the Netherlands

    Nov 1, 2011, 00:00

  • PIH6 Treatment Patterns and Associated Clinical and Economic Outcomes of Women Treated with Hormone Therapy

    Nov 1, 2011, 00:00

  • PMD20 Cost Analysis of Rechargeable Deep Brain Stimulator in Dystonia

    Nov 1, 2011, 00:00

  • PHP133 Levels of Population Risk Stratification Based on the Cost of Care in Patients with Chronic Diseases

    Nov 1, 2011, 00:00

  • PMS11 Establishing the Safety of Tumour Necrosis Factor Inhibition (TNF-I) in Rheumatoid Arthritis (RA) from an Analysis of Real World Data

    Nov 1, 2011, 00:00

  • PMD24 Cost-Effetiveness of 3M ™ Coban 2 ™ Compression System in the Treatment of Lymphoedema

    Nov 1, 2011, 00:00

  • PMD85 Sleep Questionnaires Discriminate Between Participants With and Without Overactive Bladder Symptoms

    Nov 1, 2011, 00:00

  • PRM25 Switch of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC)- The Development of a Flexible and Generic European Budget Impact Model

    Nov 1, 2011, 00:00

  • PSY9 A Budget Impact Model of Rituximab Introduction in Wegener Granulomatosis Therapies

    Nov 1, 2011, 00:00

  • PRS33 A Cost-Effectiveness Analysis of Varenicline Versus Buproprion and Nicotine Replacement Therapy in Greece

    Nov 1, 2011, 00:00

  • PMH46 The Quality of Life of Children With ADHD and their Parents- Results of EQ-5D and Kidscreen-10

    Nov 1, 2011, 00:00

  • PDB78 Reasons of UK General Practitioners for Prescribing 15- or 30-Mg of Pioglitazone in Combination with Other Oral Antihyperglycaemic Agents

    Nov 1, 2011, 00:00

  • PHP79 What Are the Research Priorities in the Spanish National Health System? A Comparison of Economic Evaluations of Health Care Interventions and Public-Funded Research

    Nov 1, 2011, 00:00

  • PND5 Efficacy and Safety of Immuno-regulatory Drugs, Interferons Beta and Glatiramer in Relapsing – Remitting Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PIN46 Cost-Effectiveness and Public Health Impact of Pneumococcal Vaccination in Malaysia

    Nov 1, 2011, 00:00

  • PMH18 The Economic and Social Consequences of Seroquel XR® (Quetiapine Prolonged Release Tablets) Reimbursement in Bipolar Disorder Treatment for Patients Currently Treated with Seroquel (Quetiapine Immediate Release Tablets) in Poland- Ana ...

    Nov 1, 2011, 00:00

  • PCN63 Cost-Effectiveness of Sunitinib in Patients with Advanced or Metastatic Pancreatic Neuroendocrine Tumors in Portugal

    Nov 1, 2011, 00:00

  • PHP119 Is There No Optimal Approach for Orphan Drugs to Patient Access? Rare Disease is Not Rare and Needs to Develop the New Pricing and Reimbursement Solution

    Nov 1, 2011, 00:00

  • PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b- A Cost-Effectiveness Analysis for the Portuguese NHS Setting

    Nov 1, 2011, 00:00

  • PMS57 Preliminary Psychometric Validation of the Sleep Disturbance and Sleep Adequacy Subscales of the 1-Week Recall Medical outcomes Study Sleep Scale in Patients with Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PRM65 Should We Aggregate Cost-Effectiveness over an Intervention's Entire Implementation Lifetime?

    Nov 1, 2011, 00:00

  • PMH70 Economic Impact of Focal Epilepsy in Spain- Results of the Espera Study

    Nov 1, 2011, 00:00

  • PDB29 Modeling the Impact of Enhanced Treatment of Type 2 Diabetes Mellitus in Bulgaria

    Nov 1, 2011, 00:00

  • PRS13 Specific Immunotherapy and the Economic Implications from the Perspective of German Statutory Health Insurance - a Budget-Impact Modeling Approach

    Nov 1, 2011, 00:00

  • PCN6 Impact of 5-HT3 Receptor Antagonist Selection Within Triple Antiemetic Regimens on the Risk of Uncontrolled Chemotherapy-Induced Nausea in Patients with Cancer Treated with Highly Emetogenic Chemotherapy

    Nov 1, 2011, 00:00

  • PRM11 Learning Effect in Economic Evaluations of Health Care Interventions

    Nov 1, 2011, 00:00

  • PRS58 Treatment Outcomes of New Smear Positive Pulmonary Tuberculosis Patients in North East Libya

    Nov 1, 2011, 00:00

  • PCN28 Capecitabine for the Treatment of Breast Cancer in Private Health System in Brazil- Cost analysis Based on Real World Data

    Nov 1, 2011, 00:00

  • PSS15 Burden of Chronic Tinnitus in Hungary

    Nov 1, 2011, 00:00

  • PDB59 Nocturnal Hypoglycemic Events- Impacts on Patients Functioing, Well-Being and Diabetes Management

    Nov 1, 2011, 00:00

  • PMH5 Empirically-Driven Definitions of “Good” “Moderate” and “Poor” Levels of Functioning in the Treatment of Schizophrenia

    Nov 1, 2011, 00:00

  • PND3 Risk-Benefit Analysis of Therapy in Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care- Comparing Infliximab to Methotrexate and Systemic Steroids

    Nov 1, 2011, 00:00

  • PCV1 Costs, Length of Stay and ALL-Cause Mortality in Ruptured Versus Unruptured Cerebral Aneurysm Among Inpatients in the United States

    Nov 1, 2011, 00:00

  • PCV89 Cost-Effectiveness Analysis of Rosuvastatin Versus Generic Atorvastatin in Patients at High Cardiovascular Risk in Spain

    Nov 1, 2011, 00:00

  • PIH14 Rates and Predictors of Chlamydia re-Screening among Privately insured Patients with Chlamydia in 2007- 2009

    Nov 1, 2011, 00:00

  • PCN51 Health Care Resources and Costs Across Lines of Therapies in Insured Patients with Metastatic Breast Cancer in the United States

    Nov 1, 2011, 00:00

  • PSU25 Effectiveness of Minimally Invasive Surgery for Total Hip Arthroplasty

    Nov 1, 2011, 00:00

  • PMD81 Decision Analytic Models Used in Estimating the Cost-Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents

    Nov 1, 2011, 00:00

  • HS4 Impacto Economico En La Atencion Medica De Enfermedades Asociadas Al Tabaquismo En Una Poblacion Mexicana

    Nov 1, 2011, 00:00

  • PMD22 Economic Evaluation of Amino-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) Test in Patients with Dyspnea attending to Emergency Department (ED) in Spain

    Nov 1, 2011, 00:00

  • PSS42 Evaluation of the Impact of Writing Exercises and Educational Interventions on Quality of Life in Patients With Psoriasis

    Nov 1, 2011, 00:00

  • PMS75 Explanatory Factors for the Rheumatoid Arthritis Patients' Access to Biological Agents in 15 European Countries

    Nov 1, 2011, 00:00

  • PND30 Cost-Effectiveness of Early vs. Non-Early Intervention in Acute Migraine with Almotriptan in Spain

    Nov 1, 2011, 00:00

  • PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral Olanzapine

    Nov 1, 2011, 00:00

  • PDB9 Weight Loss, Independent of Drug Class, Predicts HbA1c Goal Attainment in Patients 65 Years and Older in a Real-World Setting

    Nov 1, 2011, 00:00

  • MA2 Mapping Fact-P to Country Specific Patient Health Status Measured by EQ-5D in Metastatic Castrate Resistant Prostate Cancer Patients

    Nov 1, 2011, 00:00

  • PCV99 Utilisation of Renin –Angiotensin System Agents Involved in Treatment of Cardiovascular Diseases in Slovak Republic

    Nov 1, 2011, 00:00

  • PDB19 Prevalence of Diabetes Mellitus Among Patients with Vascular Complications in Poland

    Nov 1, 2011, 00:00

  • PCV141 Current Management Pathway of Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in Greece. Results from Aptorii Study

    Nov 1, 2011, 00:00

  • PCV93 the Polypill in the Primary Prevention of Cardiovascular Disease- Cost-Effectiveness in the Dutch Population

    Nov 1, 2011, 00:00

  • PHP50 Irrational Use of Injectable Form of Dexamethasone- A Warning for Health System in Iran

    Nov 1, 2011, 00:00

  • PRM10 to Get the Right Price – A Decision Support Method to Optimize Managerial Decisions on Public Funding Price to Apply for

    Nov 1, 2011, 00:00

  • PMD10 Impact Analyses of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients with Multivessel Disease in France and Belgium

    Nov 1, 2011, 00:00

  • PHP23 La Aceptacion De Las Vacunas En Los programas Nacionales De inmunizacion En Latina America- Un Estudio Comparativo

    Nov 1, 2011, 00:00

  • PSS3 Incidence and Characteristics of Patients with Macular Edema Secondary to Retinal Vein Occlusion in A Representative Canadian Cohort

    Nov 1, 2011, 00:00

  • PCV87 Ticagrelor for the Treatment of Acute Coronary Syndromes (ACS)- A Dutch Analysis Based on the Plato Trial

    Nov 1, 2011, 00:00

  • PHP168 Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption

    Nov 1, 2011, 00:00

  • PIN107 Tobramycin Inhaled Solution Utilization by Cystic Fibrosis Patients- An Analysis with the RAMQ Database

    Nov 1, 2011, 00:00

  • PCV116 The Impact of High Risk of Stroke Patients Diagnosed with atrial Fibrillation on Health-Related Quality of Life, and Health Care Use in 5EU

    Nov 1, 2011, 00:00

  • PUK5 ANÁlisis Comparativo De Costos Del Tratamiento Para La Anemia Renal Con Metoxi POLIETILENGLICOL-Eritropoyetina Beta (MIRCERA®) VS. Eritropoyetina ALFA

    Nov 1, 2011, 00:00

  • PDB44 An Economic Evaluation of the Use of Pioglitazone in Italy Using Proactive

    Nov 1, 2011, 00:00

  • PCN174 Variations in Drug Administration Costs for Stage III/IV NSCLC in Europe

    Nov 1, 2011, 00:00

  • CN2 Cancer De Pulmon Y Tabaco, Analisis Del Costo De Atencion Medica

    Nov 1, 2011, 00:00

  • PMD66 Demand for Routine in office Follow-up Visits for Cardiac Implantable Electrical Devices (CIED) in Germany and the United Kingdom

    Nov 1, 2011, 00:00

  • PHP7 Impact of Global Health Care Reforms on Pricing, Access and Health Economics and outcomes Strategy

    Nov 1, 2011, 00:00

  • PRM31 Data Pooling of Patient-Reported Outcomes in Clinical Trials- Evaluation of Structual Equation Modelling for Assessing Equivalence

    Nov 1, 2011, 00:00

  • PSY16 Cost and Quality of Life Benefits of Faster Bleed Resolution with an Rfviia Analogue- a Mathematical Simulation Study for the German Population

    Nov 1, 2011, 00:00

  • PIN60 Cost-Effectiveness of Telbivudine in First Line Treatment of Hbeag-Positive Patients with Chronic Hepatitis B (CHB) in the Turkish Health Care Setting

    Nov 1, 2011, 00:00

  • PHP76 The Lack of BIA Methodology in the Czech Republic Leads to Inappropriate Public Health Insurance Budgeting

    Nov 1, 2011, 00:00

  • PRM8 Could Corporate Social Responsibility Predict Pharmaceutical Corporate Financial performance?

    Nov 1, 2011, 00:00

  • PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological Therapy

    Nov 1, 2011, 00:00

  • PND4 El Impacto Economico Del Tabaquismo En El Desarrollo De La Enfermedad Vascular Cerebral En Un Centro Neurologico De Tercer Nivel

    Nov 1, 2011, 00:00

  • PSY52 Impact of Two Different Treatment Approaches on Epidemiology of inhibitor Hemophilia in Russia

    Nov 1, 2011, 00:00

  • PCN41 Hospital Health Care Costs for the Management of HER2-Positive Breast Cancer with Brain Metastases

    Nov 1, 2011, 00:00

  • PIN8 A Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without “Tenofovir Add-on as Needed” and Lamivudine with or without “Tenofovir Add-on as Needed” in the Treatment of Chronic Hepatitis B Infection ...

    Nov 1, 2011, 00:00

  • PSS7 Prevalence Assessment of Diabetic Macular Edema With Visual Impairment in Spain- A Prevail Study

    Nov 1, 2011, 00:00

  • PRS74 Measurement Of A Possible Patch Testing Outcome Indicator

    Nov 1, 2011, 00:00

  • PGI32 An Investigation into the Extensive Spectrum of Agents Used for the Management of Post-Operative Ileus

    Nov 1, 2011, 00:00

  • PDB65 Unmet Need and Drug Management Challeneges in Elderly Type 2 Diabetes Medicare Part D Population

    Nov 1, 2011, 00:00

  • PIN63 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in Panama

    Nov 1, 2011, 00:00

  • PHP159 Structures for the Role of Health Technology Assessment in Translational Research

    Nov 1, 2011, 00:00

  • PCN199 An Evaluation of Statistical Methods Used to Analyse Patient-Reported Outcomes (PRO) Data in Published Metastatic Cancer Studies

    Nov 1, 2011, 00:00

  • PMH75 Physician Differences between Italy and Germany- The Treatment of Opioid Dependence with Substitution Therapy

    Nov 1, 2011, 00:00

  • PSY1 Epidemiology And Socioeconomic Burden Of Overweight And Obesity In Argentina

    Nov 1, 2011, 00:00

  • PCV23 Clopidodgrel and Statin Prescribing Patterns in ACS Patients – an Observational Study Using Linked Secondary and Primary Care Data in a UK Population 2003-2009

    Nov 1, 2011, 00:00

  • PCN124 The Impact of Condition Labelling on Health State Values

    Nov 1, 2011, 00:00

  • HS3 The Economic Burden of Road Traffic Injuries on Health System and Society in Belize

    Nov 1, 2011, 00:00

  • PDB40 Economic Analysis of Diabetes Treatment Goals Defined by Polish Diabetes Association- How Much Does Cost-Effective Treatment Cost?

    Nov 1, 2011, 00:00

  • PMS50 Cost-Effectiveness of Biologic Agents Compared with Methotrexate in the Treatment of Rheumatoid Arthritis in Colombia

    Nov 1, 2011, 00:00

  • PHP22 Are Hospital Medicines Prices Influenced by Discounts and Rebates?

    Nov 1, 2011, 00:00

  • PDB10 Economic Evaluation of Duloxetine as First-Line Treatment for Painful Diabetic peripheral Neuropathy in Mexico

    Nov 1, 2011, 00:00

  • VI2 A Novel Approach to analysing Value Driver Importance Across Multiple Target Product Profiles

    Nov 1, 2011, 00:00

  • PCN2 Cost-Effectiveness and Budget Impact Analysis of an Immediate Care Center at the National Cancer Institute, Mexico

    Nov 1, 2011, 00:00

  • PRM47 Review of Clinician and Observer Reported Outcomes Measures Translation Methodologies

    Nov 1, 2011, 00:00

  • PDB53 Diabetes Medication Adherence and Glycemic Control in Penang, Malaysia

    Nov 1, 2011, 00:00

  • PSY45 Impact of Lupus on Career Choices and Work productivity in Five European Countries- Results from the Lupus European Online (Leo) Survey

    Nov 1, 2011, 00:00

  • PMH31 Cost-Effectiveness of Long-Acting Olanzapine Versus Long-Acting Risperidone in Patients with Schizophrenia in Spain

    Nov 1, 2011, 00:00

  • PMD56 A Systematic Literature review on the Clinical and Economic outcomes attributable to the Use of Hemostatic Matrix during Tonsillectomy and Adenoidectomy

    Nov 1, 2011, 00:00

  • PHP37 Cross-Continental Comparison of HTA Evolution in Emerging Markets- Brazil, India and Poland

    Nov 1, 2011, 00:00

  • PUK6 BPH Patients Treated with Phytotherapy in Portugal- Results at Six Months

    Nov 1, 2011, 00:00

  • IN3 Dengue MÁs Que Un Problema De Salud PÚblica- EstimaciÓn De Los Costos Directos De La Epidemia Del AÑo 2010 En Colombia

    Nov 1, 2011, 00:00

  • PHP44 Characteristics of Patients Treated for Fibromyalgia in Puerto Rico and the United States- Baseline Findings of the Reflections Study (Real World Examination of Fibromyalgia- Longitudinal Evaluation of Costs and Treatments)

    Nov 1, 2011, 00:00

  • PSS25 the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Observation for the Treatment of Macular Oedema Following Central and Branch Retinal Vein Occlusion

    Nov 1, 2011, 00:00

  • PCN38 Economic Evaluation of Darbepoetin Alpha in the Management of Patients with Chemotherapy Induced Anemia (CIA) in Greece

    Nov 1, 2011, 00:00

  • PC1 The Use and Performance of Productivity Scales to Evaluate Presenteeism in Mood Disorders

    Nov 1, 2011, 00:00

  • PCN133 Measuring Patients' Expectation and Satisfaction With Integrative Cancer Therapy

    Nov 1, 2011, 00:00

  • PMH25 Cost of Delivering Psychiatric Inpatient Care to Mental Health Patients with Psychosis and Co-Occuring Substance Use- A UK-Based Study

    Nov 1, 2011, 00:00

  • PSU27 Fracture Related Treatments After Primary Surgical Interventions of Hip Fracture Eight Years Follow Up

    Nov 1, 2011, 00:00

  • EX4 Efectividad De Los indicadores De Calidad De La Prescripción Regionales En El Sns Español

    Nov 1, 2011, 00:00

  • PHP49 The Pharmacist'S Perception of the Splitting Extended Release and Enteric-Coated Formulation Drugs

    Nov 1, 2011, 00:00

  • PDB24 Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients with Hyperglycaemia in Italy

    Nov 1, 2011, 00:00

  • PMS36 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in Colombia

    Nov 1, 2011, 00:00

  • PGI6 The Development and External Validation of a Model to Predict One Year All-Cause Mortality Following Liver Function Tests in Primary Care Patients

    Nov 1, 2011, 00:00

  • QA4 Cost-Utility of Sacral Neuromodulation Versus Augmentation Cystoplasty for Treatment of Refractory Urge Incontinence in México

    Nov 1, 2011, 00:00

  • PCN80 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in Mexico Public Insurance (Seguro Popular)

    Nov 1, 2011, 00:00

  • PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population

    Nov 1, 2011, 00:00

  • PCV62 Influence of Smoking on the Use of Health-Care resources and Costs in Patients with Cardiovascular Disease

    Nov 1, 2011, 00:00

  • PCV10 Anti-Glycemic Medication Treatment Patterns Among Type II Diabetes Mellitus Patients Initiating Lipid-Altering Regimens

    Nov 1, 2011, 00:00

  • PCV77 Economic Evaluation of Dabigatran Etexilate 150dib for the Stroke Prevention in Atrial Fibrillation in Gree A Cost –Effectiveness Analysis under the Greek NHS Setting

    Nov 1, 2011, 00:00

  • PIH50 quality of Life of Students from the Faculty of Pharmacy at Medical University of Warsaw in 2011

    Nov 1, 2011, 00:00

  • PRM53 Comparing Multiple Propensity Score Adjustment and Traditional Regression Analysis to Assess the Exposure-Outcome Association Using Retrospective Claims Data

    Nov 1, 2011, 00:00

  • PMH4 Extent of Attaining and Maintaining Symptom Remission by Antipsychotic Medication in the Treatment of Chronic Schizophrenia- Evidence from the Catie Study

    Nov 1, 2011, 00:00

  • PCV70 Cost Effectiveness of Ticagrelor in the Treatment of Acute Coronary Syndrome in Germany

    Nov 1, 2011, 00:00

  • PMS8 Prevalence of Clinical Risk Factors for Fractures in the Canadian Multicentre Osteoporosis Study

    Nov 1, 2011, 00:00

  • PIN3 Comparing the Efficacy and Tolerability of Anti-Retroviral Therapy in Treatment-Naïve HIV-1 Infected Adults- A Systematic review of Randomized Clinical Trials and Bayesian Mixed Treatment Comparisons Including Atazanavir/R, Darunavir/R ...

    Nov 1, 2011, 00:00

  • PMH42 Cost-Utility Analysis of Paliperidone Palmitate Long Acting Injection(PLAI) Versus Oral Atypical Antipsychotics in Non-Adherent Schizophrenia Patients

    Nov 1, 2011, 00:00

  • PRS46 Effectiveness and Cost-Utility Estimates of Tiotropium Treatment and Pulmonary Rehabilitation Programs in French Patients with Chronic Obstructive Pulomonary Disease

    Nov 1, 2011, 00:00

  • PCN9 Economic Evaluation of Panitumumab vs Cetuximab in Patients with Colorectal Carcinoma (CRCM) with Non-Mutated (WILD-TYPE) Kras After Failure of Chemotherapy Regimens in Mexico

    Nov 1, 2011, 00:00

  • PCV56 the Economic Burden of Atherothrombosis in Gree Results from the Thesis Study

    Nov 1, 2011, 00:00

  • PHP34 Pricing Insights Across Therapy Areas and European Countries - A Discussion of International Price References and Implications for Parallel Trade and Prescription Patterns of Pharmaceutical Products

    Nov 1, 2011, 00:00

  • HT3 Understanding the Complexity of HTA Networks

    Nov 1, 2011, 00:00

  • PHP82 A Study Explorating the General Public Perceptions Towards Medicines

    Nov 1, 2011, 00:00

  • PHP95 Payer Perspectives on Evidence for Formulary Decision Making in the United States

    Nov 1, 2011, 00:00

  • PSY13 Efecto de un Programa de Atención Farmacéutica Para Pacientes Con Sobrepeso Y Obesos

    Nov 1, 2011, 00:00

  • PHP43 Introduction of a Prescription Charge on the Community Drug Scheme in Ireland – What Impact Has It Had on Drug Utilisation?

    Nov 1, 2011, 00:00

  • PIH34 Patient Reported Reasons for Medication Nonadheren A Survey

    Nov 1, 2011, 00:00

  • PSU11 Medico-Economic Analysis of the Impact of Malnutrition on the Post-Operative Course of Colorectal Cancer Patients

    Nov 1, 2011, 00:00

  • PDB18 Australia- Management of the Diabetic Foot with Pedimed® Under Real Use Conditions

    Nov 1, 2011, 00:00

  • PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PMD70 A Review of the Geographic Variations in the Implant Rate of Transcatheter Aortic Valves in 14 European Countries

    Nov 1, 2011, 00:00

  • PMD54 Resource Utilisation Related to Catheter-associated Urinary Tract infections in Swedish Spinal injury Patients

    Nov 1, 2011, 00:00

  • PGI20 Pharmacoeconomic Study of Glutamine Dipeptide Usage During Total Parenteral Nutrition (TPN)

    Nov 1, 2011, 00:00

  • PRM56 Differential Discounting- Questioning the Assumption of Healthcare Resource Fungibility Over Time

    Nov 1, 2011, 00:00

  • PDB43 The Economic Impact of Weight Loss in Patients Newly Diagnosed with Type 2 Diabetes Mellitus (T2DM) and Younger Than Fifty in Sweden

    Nov 1, 2011, 00:00

  • PRM46 Linguistic Validation and ePRO – Value of Collaboration

    Nov 1, 2011, 00:00

  • PSU28 Economic Impact of Stereotactic Radiosurgery for Malignant Intracranial Brain Tumors

    Nov 1, 2011, 00:00

  • PND17 Treatment Experience, Burden, and Unmet Needs (Tribune) in Multiple Sclerosis Study- Excess Burden Due to Relapses

    Nov 1, 2011, 00:00

  • PCN196 Review of Cost Effectiveness of Trastuzumab in Early Breast Cancer

    Nov 1, 2011, 00:00

  • PCN123 A Literature Review on Utility Values Associated With HPV-Related Diseases

    Nov 1, 2011, 00:00

  • PMS35 A Cost-Effectiveness Analysis of Denosumab for the Treatment of Post-Menopausal Osteoporosis in Greece

    Nov 1, 2011, 00:00

  • PSY27 Cost-Consequence Analysis Comparing Romiplostim to Rituximab in the Treatment of Adult Primary Immune Thrombocytopenia (Itp) in France

    Nov 1, 2011, 00:00

  • CN1 Cost-Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer in Six Latin American Countries

    Nov 1, 2011, 00:00

  • PRM60 Assessing Relative Clinical Value Across Tumor Types in Metastatic Disease

    Nov 1, 2011, 00:00

  • PDB8 Cost-Effectiveness Study of Oral Hypoglycemic Agents in Outpatients Diagnosed with Type-2 Diabetes Attending a Primary Care Public Clinic in Mexico City

    Nov 1, 2011, 00:00

  • PCN169 Differences in the Use of Innovative Anti-Cancer Drugs Among French Hospitals

    Nov 1, 2011, 00:00

  • PMH27 An Economic Analysis of the Impact of Crime and Hospitalisation Associated with Different Interventions for Opioid Abuse in the United Kingdom

    Nov 1, 2011, 00:00

  • PCN102 Economic Evaluation of Three Formulations of Leuprolide Acetate With Atrigel® in Androgen Deprivation Therapy for Advanced Prostate Cancer in Nine European Countries

    Nov 1, 2011, 00:00

  • PMS6 A Network Meta-analysis of Biologic Treatments in TNF-IR Rheumatoid Arthritis Patients

    Nov 1, 2011, 00:00

  • PCV12 Differences in the Weighted Average Daily Doses of Statins in Europe and Their Potential Impact on Cardiovascular Outcomes

    Nov 1, 2011, 00:00

  • PHP47 AvaliaÇÃo Do Mercado De Antimicrobianos No Brasil- Passo Para ImplantaÇÃo Do Monitoramento E Controle SanitÁrio Em Estabelecimentos FarmacÊuticos

    Nov 1, 2011, 00:00

  • PND23 Cost of the Informal Care of Multiple Sclerosis in Spain

    Nov 1, 2011, 00:00

  • PIN7 The Comparative Efficacy of Telaprevir Versus Boceprevir in Treatment-Naive and Treatment-Experienced Patients with Genotype 1 Chronic Hepatitis

    Nov 1, 2011, 00:00

  • PSU22 Performance of the Functional Assessment of Visual Tasks (VISTAS-18) among Cataract Patients Receiving Monofocal and Multifocal Intraocular Lens Implants

    Nov 1, 2011, 00:00

  • PND52 Responsiveness of the Multiple Sclerosis International Quality of Life and Short Form-36 Questionnaires to Expanded Disability Status Scale Score Changes in Subjects with Multiple Sclerosis- Final 24-Month Results From An Internationa ...

    Nov 1, 2011, 00:00

  • PND62 What Are The Key Drivers for Changing HTA Decisions? Example of Alzheimer'S Disease Treatment in Germany, France and UK

    Nov 1, 2011, 00:00

  • PUK15 A Simulation Model of The Effects of Treatments for Secondary Hyperparathyroidism on Mortality

    Nov 1, 2011, 00:00

  • PMS78 Measurement Strategy for Kyphosis- New Evidence from Patients and Physicians

    Nov 1, 2011, 00:00

  • PMH84 The Cornell-Brown Scale for Quality of Life in Dementia- Spanish Adaptation and Validation

    Nov 1, 2011, 00:00

  • PDB23 Budget Impact Analysis of the Reimbursement of Long-Acting Insulin Analogues in Poland

    Nov 1, 2011, 00:00

  • PCV20 Duration of Action of Aliskiren in Hypertensive Patients with Diabetes – Implications for Control of Blood Pressure in Real-World Use in Imperfectly Adherent Patients

    Nov 1, 2011, 00:00

  • PMS19 The Economic Burden of Post-Menopausal Osteoporosis and Related Fractures in Greece

    Nov 1, 2011, 00:00

  • PSY11 Budget Impact Model of Hemophilia a Treatment in Turkey- a Payer'S Perspective

    Nov 1, 2011, 00:00

  • PRM43 Direct from the Patients – Research Into What Patients Would Like to Improve in Their Electronic Diary Experience

    Nov 1, 2011, 00:00

  • PMS44 Cost-Effectiveness of Denosumab in the Treatment of Postmenopausal Osteoporosis in Scotland

    Nov 1, 2011, 00:00

  • PIN101 New Insights on the Spread of Influenza Through Agent Based Epidemic Modeling

    Nov 1, 2011, 00:00

  • PIN93 Assessment of Knowledge and Awareness of Hepatitis B Among General Public in Pakistan

    Nov 1, 2011, 00:00

  • PCN176 Cancer Drug Prices in the United States and the United Kingdom- Implications for Pricing Strategy and Drug Access

    Nov 1, 2011, 00:00

  • PMS67 Determining the True Impact of Dupuytren'S Disease- A Qualitative Study

    Nov 1, 2011, 00:00

  • PDB72 The Burden of Hypoglycaemia in Secondary Care in England

    Nov 1, 2011, 00:00

  • PCV78 A Cost-Effectiveness Analysis of Clopidogrel Versus Aspirin in Patients with Atherothrombosis in Greece

    Nov 1, 2011, 00:00

  • PCV143 Implementation of Evidence-Based National Guidance on Venous Thrombo-Embolism Prophylaxis for Hospital Inpatients in England

    Nov 1, 2011, 00:00

  • PIN50 The Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination with Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients- A Within Trial Analysis from the Perspective of the ...

    Nov 1, 2011, 00:00

  • PCN61 Impact of Appropriate Treatment Informed by EGFR Mutation Status on Patient Outcomes from Diagnosis to Death in Advanced Non-Small Cell Lung Cancer

    Nov 1, 2011, 00:00

  • PCV103 Estimating the Impact of Adherence to Allopurinol Therapy on Cardiovascular Outcomes in Gout Patients Using the Health Improvement Network (THIN) General Practice Database

    Nov 1, 2011, 00:00

  • PCV25 Characterising Patients with A First-Time Admission for atrial Fibrillation in the United Kingdom

    Nov 1, 2011, 00:00

  • PND14 Comparing Expected Costs associated with Three Screening Strategies for Cystic Fibrosis Along Spain

    Nov 1, 2011, 00:00

  • PCN17 Correlations Between Surrogate End Points and overall Survival in Advanced or Metastatic Breast Cancer

    Nov 1, 2011, 00:00

  • PRM26 A Literature Review of Methods Used to Estimate Mean Preference-Based Utilities for Comorbidities Using Published Summary Statistics

    Nov 1, 2011, 00:00

  • PDB66 Achievement of Glycemic Control and Relapse Among Patients Initiating Basal Insulin from a Geographically-Diverse Us Electronic Medical Record (EMR) Database

    Nov 1, 2011, 00:00

  • PIN71 Pharmacoeconomic Analysis of Treatment of Community-Acquired Pneumonia (CAP)

    Nov 1, 2011, 00:00

  • PHP80 Where A Cheap Medicine is Not the Same as A Generic Medicine- The Belgian Case

    Nov 1, 2011, 00:00

  • EX3 Incremental Cost of Implementing A Care Program for People with Type 2 Diabetes in Argentina

    Nov 1, 2011, 00:00

  • PCN157 The Impact of a Patient Support Program on Access to Oral Oncology Therapy in the United States

    Nov 1, 2011, 00:00

  • PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United Kingdom

    Nov 1, 2011, 00:00

  • PIH63 The KIGS Quality Insight Program Assessing the Quality of Care for Short Children Treated with Growth Hormone Using the Output from a Large Pharmaco-Epidemiological Survey

    Nov 1, 2011, 00:00

  • PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III Trial

    Nov 1, 2011, 00:00

  • PCN177 Assessment of Reimbursement Processes and Outcomes for Cancer Drugs in Croatia – Comparison to NICE and NCCN Guidelines

    Nov 1, 2011, 00:00

  • PMD32 Cost Effectiveness of Cervical Cancer Screening in Serbia- A Comparison of Screening Policies

    Nov 1, 2011, 00:00

  • PIH15 Estimating Herpes Zoster Disease Burden in Germany

    Nov 1, 2011, 00:00

  • PIN113 A New Framework for Understanding the Impact of Hepatitis C and Its Treatment on Quality of Life

    Nov 1, 2011, 00:00

  • PHP68 Assessment of the NHS Hospitals' Productivity in the Regional Health Authority of Thessaly in Greece

    Nov 1, 2011, 00:00

  • PHP147 Opinions on Market Access Needs Differ Between Cultures and Stakeholder Sectors – Results of a Survey of ISPOR Delegates

    Nov 1, 2011, 00:00

  • PCN74 Cost-Effectiveness Analysis of Chemoprevention for Colorectal Cancer by Low Dose Aspirin in South Korea

    Nov 1, 2011, 00:00

  • PMS9 Prevalence of Shoulder Osteoarthistis and Treatment in A Large US Managed Care Population

    Nov 1, 2011, 00:00

  • PRM3 Challenges to Obtain Real-Life Data in Observational Studies- What are the Solutions When the Patient is the Main Data Provider?

    Nov 1, 2011, 00:00

  • PCN13 Treatment of Patients with Multiple Myeloma (TLN-Registry)- A “Real Life” Overview of Treatment by Office-Based Oncologists in Germany

    Nov 1, 2011, 00:00

  • PMD74 Home Dialysis Modalities- The Development of A Framework to Identify and Quantify Favourable Renal Policy and Reimbursement Factors

    Nov 1, 2011, 00:00

  • PSY5 Estudio Costo-Efectividad Del Parche De LidocaÍna Como Terapia Adyuvante A Pregabalina Y Gabapentina En El Manejo Del Dolor NEUROPÁtico PERIFÉrico En El Hospital San José De Bogotá D.C. Enero-Diciembre 2010

    Nov 1, 2011, 00:00

  • PCV35 Safety and Tolerability of Bisoprolol Compared to Atenolol in Patients with Mild to Moderate Hypertension

    Nov 1, 2011, 00:00

  • PC4 Health Services Utilization, Work absenteeism and Costs of Pandemic influenza A (H1N1)

    Nov 1, 2011, 00:00

  • PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel Therapy

    Nov 1, 2011, 00:00

  • PMD35 Cost-Effectiveness Analysis of the Corail Hip System for Primary total Hip Arthroplasty in Spain

    Nov 1, 2011, 00:00

  • PIH24 Intra Muscular Testosterone Undecanoate (TU) (NEBIDO®) as Testosterone Replacement Therapy (TRT) for Androgen Deficiency in the Aging Male (ADAM) and Diabetes Mellitus Type 2 (DM2) Patients- Brazilian Economic Modeling

    Nov 1, 2011, 00:00

  • PCV126 Multidimensional Non-Interventional Study to Assess Current Practice, Utilization of Resources and Costs Related to Anticoagulation Treatment in Poland – “Economedica”

    Nov 1, 2011, 00:00

  • PHP26 A SatisfaÇÃo Dos Profissionais De SaÚde vs A SatisfaÇÃo Dos Utentes Em Unidades De Cuidados Continuados

    Nov 1, 2011, 00:00

  • PRS76 Systematic Literature Review of Conceptual Models to Inform Economic Modelling in COPD

    Nov 1, 2011, 00:00

  • PRS48 Cost-Utility Analysis of Varenicline vs Existing Smoking Cessation Strategies in EL Salvador

    Nov 1, 2011, 00:00

  • PCN16 Disease Burden and Treatment outcomes in Second-Line Therapy of Patients with Estrogen-Receptor Positive (ER+) Advanced Breast Cancer- A Review of the Literature

    Nov 1, 2011, 00:00

  • PMS13 The Burden of Juvenile Idiopatic Arthritis (JIA) in Russia- A Retrospective Review of Direct and Indirect Costs

    Nov 1, 2011, 00:00

  • PIN83 Cost-Effectiveness and Cost-Utility analysis of 200 Days Prophylaxis of Cytomegalovirus (CMV) infections in High Risk (D+/R-) Kidney Transplant Recipients in Poland

    Nov 1, 2011, 00:00

  • PIH26 Economic Evaluation of Dienogest for Endometriosis in the Context of Korea National Health insurance

    Nov 1, 2011, 00:00

  • QA2 Analisis De Costo-Utilidad De Rituximab Posterior Al Fallo Por Anti-Tnf En Artritis Reumatoide Para Colombia

    Nov 1, 2011, 00:00

  • PUK3 Sources of Heterogeneity Among Overactive Bladder Clinical Trial Estimates of Tolterodine and Fesoterodine Reductions of Urgency Urinary Incontinence Episodes Relative to Placebo

    Nov 1, 2011, 00:00

  • PRS59 Quality of Life in Severe Persistent Uncontrolled Asthma- Patients and Caregivers in the Spanish Pediatric Population- A Prex Study

    Nov 1, 2011, 00:00

  • PUK3 COST-Effectiveness Of Anemia Treatment In Dialysis Patients In BRAZIL

    Nov 1, 2011, 00:00

  • PCV14 Mixed Treatment Comparison of Dronedarone, Amiodarone and Sotalol for the Management of Atrial Fibrillation in Australia

    Nov 1, 2011, 00:00

  • PHP62 Establish Drugs Optimal Purchase Model

    Nov 1, 2011, 00:00

  • PCV61 are Hospital Costs for Stroke Underestimated in Spain?

    Nov 1, 2011, 00:00

  • PMH34 Cost-Utility of Amisulpride Compared with First Generation Antipsychotics in Treatment of Schizophrenia in Poland

    Nov 1, 2011, 00:00

  • PND67 A Mixed-Effects Piecewise Linear Model of the Rate of Lung Function Decline Before and After the Clinical Use of Dornase Alfa in an Observational Study of Cystic Fibrosis

    Nov 1, 2011, 00:00

  • PR3 Industry Preparedness against German reforms

    Nov 1, 2011, 00:00

  • PHP155 Review of Cost Effectiveness Models of High Budget Impact Drugs

    Nov 1, 2011, 00:00

  • PMD55 Resource Utilisation related to Urinary Tract infections in Swedish Self-Catheterisation Patients

    Nov 1, 2011, 00:00

  • PCN72 Cost - Effectiveness Analysis of Cervical Cancer Vaccination Strategies in Spain

    Nov 1, 2011, 00:00

  • PCV52 Temporal Trends in the Hospital Burden of Atrial Fibrillation and Stroke on Secondary Care Costs in England Between 2006 and 2009

    Nov 1, 2011, 00:00

  • PRS21 Resource Utilization and Associated Costs of Community Acquired Pneumonia (CAP) in Adults- Observational Study in a Population Setting in a Well Defined Area of Barcelona (Badalona, Spain)

    Nov 1, 2011, 00:00

  • PCV102 Evaluation of the Measurement Properties of the Antihypertensive Adherence Survey

    Nov 1, 2011, 00:00

  • HT4 What Determines the Recommendations Issued by Polish Health Technology Agency (AHTAPol)?

    Nov 1, 2011, 00:00

  • PCV57 Epidemiological Structure, Socioeconomic Effects and Burden of Disease in Patients with Oral Anticoagulation and Atrial Fibrillation in Austria

    Nov 1, 2011, 00:00

  • PMH36 Cost-Effectiveness of Depot Flupentixol Versus Long-Acting Risperidone – A Markov Model Parameterized Using Administrative Data

    Nov 1, 2011, 00:00

  • PMD3 Biochemical Markers for the Identification of Intracranial Injury Following Minor Head injury- A Systematic Review and Meta-Analysis

    Nov 1, 2011, 00:00

  • PDB28 The Roleof Diabetes and Body Mass Index on Medical Expenses, an Analysis of the Medical Expenditure Panel Survey, 2008

    Nov 1, 2011, 00:00

  • EX2 Health Care Resource Use Among Patients With Bipolar Disorder From Brazil and Venezuela- Subgroup Analysis of Data From A Large Multinational Longitudinal Study (WAVE-BD Study)

    Nov 1, 2011, 00:00

  • PIN14 Prescribing Patterns of Sebivo® (Telbivudine)- A Survey Among Physicians in Selected European Countries

    Nov 1, 2011, 00:00

  • PMH81 Cost-Effectiveness Analysis of Antidepressants by the IQWIG in Germany

    Nov 1, 2011, 00:00

  • PND15 Economic Burden of Chronic Migraine in Taiwan

    Nov 1, 2011, 00:00

  • PIN98 Evaluating Optimal Treatment Outcomes of Antiviral Therapy in Hepatitis C for Prior Null Responders in the Era of First Generation Protease Inhibitors

    Nov 1, 2011, 00:00

  • PIH43 Changes in Health-Related Behaviours and their Impact on Academic Achievement and Health-Related Quality of Life (HRQOL) Among Spanish Adolescents

    Nov 1, 2011, 00:00

  • PHP46 PrÁctica Clínica Institucional En El Tratamiento De La Diabetes Mellitus Tipo 2 En MÉxico

    Nov 1, 2011, 00:00

  • PSS26 The Use of A Mixed-Treatment Comparison to Assess the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Bevacizumab Intravitreal Injections for Patients With Macular Oedema Following Branc ...

    Nov 1, 2011, 00:00

  • PSU17 Cost-Effectiveness of DSAEK Versus PK for Corneal Endothelialdisease

    Nov 1, 2011, 00:00

  • PHP35 Is Value Based Pricing Executed In Real Life Situation? – Global Perspectives

    Nov 1, 2011, 00:00

  • PRM37 Assessing the Health Status of Roma Population by Using SF-36 Health Survey- Evidence from Greece

    Nov 1, 2011, 00:00

  • PMD9 A1CNow® as Ambulatory Monitoring of Glycated Hemoglobin in Diabetic Type 2 (DM2) Patients- Systematic Review

    Nov 1, 2011, 00:00

  • PCN31 Sequential Treatment of Metastatic Renal Cell Carcinoma with Targeted Therapies- Adverse Events Associated Costs, from the Public and Private Perspectives in Brazil

    Nov 1, 2011, 00:00

  • PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) Perspective

    Nov 1, 2011, 00:00

  • PCN130 Utility Weights for Skeletal Related Events in Castration Resistant Prostate Cancer

    Nov 1, 2011, 00:00

  • PGI30 Comparison of Health Related Quality of Life Between Hepatitis, Cirrhosis, Liver Transplantation and Hepatic Carcinoma- Results of the Come Study

    Nov 1, 2011, 00:00

  • PMD83 Using Five Existing Models to Comprehensively Model the Cost-Effectiveness of A High Definition CT Scanner in A Coronary Artery Disease Population- A Nice Diagnostic Guidance Project

    Nov 1, 2011, 00:00

  • PSU7 Implications of Alloarthroplastic Infections in Hip and Knee Surgery

    Nov 1, 2011, 00:00

  • PND47 The Huntington Clinical Self-Reported Instrument (H-CSRI)- Validation in Germany, Poland and USA

    Nov 1, 2011, 00:00

  • PRS27 Trends in Uk Smoking Cessation Prescription Expenditure Over Time - a Thin Database Study

    Nov 1, 2011, 00:00

  • MT2 The Use of Continuous Data versus Categorical Data in MTC- The Case of HAQ Multiplier in Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PSU19 the Doors-Study of On-Pump Versus Off-Pump Coronary Artery bypass Grafting- A Post Hoc Analysis of Methods for Multiple Imputation of Missing Data in Economic Evaluation

    Nov 1, 2011, 00:00

  • PRM59 Estimating the Confidence Interval for the Cost-Effectiveness Ratio from A Family of Regressions on Net Monetary Benefit

    Nov 1, 2011, 00:00

  • PMD79 An Evaluation of the Non-invasive Imaging Tests Used in Current Care of Tia and Minor ischemic Stroke in the Netherlands- How Much Practice Variation is There?

    Nov 1, 2011, 00:00

  • MA3 Mapping the Diabetes Health profile (DHP-18) onto the EQ-5D and SF-6D Generic Preference Based Measures of Health

    Nov 1, 2011, 00:00

  • PSY14 Differences in Outpatient Care Among Fibromyalgia Patients on Duloxetine Versus Pregabalin

    Nov 1, 2011, 00:00

  • PIH8 Impact Assessment of Sport- Recreation Training

    Nov 1, 2011, 00:00

  • PCV2 Evaluation of the prophylaxis Patterns and 90 Day outcome Events in Hospitalized Medically Ill Patients

    Nov 1, 2011, 00:00

  • PSS29 Treatment Patterns of Psoriasis Patients and Trends Over Time

    Nov 1, 2011, 00:00

  • PHP88 Societal Unmet Needs within Spain

    Nov 1, 2011, 00:00

  • PIN77 Cost Effectiveness of De-Escalation from Micafungin in the Treatment of Patients with Systemic Candida Infections Compared to Traditional Escalation from Fluconazole

    Nov 1, 2011, 00:00

  • PCV90 Development of an Institutional Cost of Care Model for Anticoagulation Management of Patients with Warfarin Versus Novel Oral Agents

    Nov 1, 2011, 00:00

  • PCN127 Health State Utility Assessment for Breast Cancer

    Nov 1, 2011, 00:00

  • PRM28 Bayesian Inference in Mixed Treatment Comparisons (MTC) with Continuous Outcomes

    Nov 1, 2011, 00:00

  • PCN83 Cost-Effectiveness Analysis of Combination Therapies Including Class II Anticancer Drug for Advanced or Metastatic Gastric Cancer

    Nov 1, 2011, 00:00

  • PIN2 Safety and Efficacy of Tenofovir as Compared to Other Nucleot(s)ide Analogues in the Treatment of Chronic Hepatitis B – A Systematic review with Mixed Treatment Comparison

    Nov 1, 2011, 00:00

  • PRS3 The Effect Of Aat Replacement Therapy on Patient Length And Quality Of Life - a Markov Model

    Nov 1, 2011, 00:00

  • PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term Patients

    Nov 1, 2011, 00:00

  • PCV137 The Impact of Dementia on Care Patterns After Discharge for Acute Coronary Syndromes Under National Health Insurance System

    Nov 1, 2011, 00:00

  • PCV65 Clinico-Economic Evaluation of Complex Cardiovascular Therapy with Magnesium Orotate in Patients with Chronic Heart Failure Versus Standard Therapy in Ukraine

    Nov 1, 2011, 00:00

  • PRM55 A New Approach to Modeling Cancer Recurrence and Follow-Up

    Nov 1, 2011, 00:00

  • PSY8 Two Analgesic Techniques After Cesarean DELIVERY- A COST-Effectiveness Analysis Study

    Nov 1, 2011, 00:00

  • PND2 Cost Offsets and Gains in Health Effects in the Treatment of Relapsing–Remitting Multiple Sclerosis with Laquinimod- An Analysis Based on the Allegro Trial

    Nov 1, 2011, 00:00

  • PSY4 Comparison of Infliximab and Ustekimumab for Treatment of Moderate to Severe Psoriasis- a Mixed Treatment Meta-Analysis

    Nov 1, 2011, 00:00

  • PMH78 Retrospective Prescription Analysis of Dementia in a South Indian Psychiatric Hopital

    Nov 1, 2011, 00:00

  • PR2 Value-Based Pricing in the UK- Developing an Evaluation Framework for Burden of Illness

    Nov 1, 2011, 00:00

  • PGI3 AdaptaciÓn De Un ANÁlisis De Costo-Efectividad Del Entecavir vs InterferÓn Pegilado Alfa a Venezuela

    Nov 1, 2011, 00:00

  • PRS17 Prevalence and Cost of Severe Chronic Hand Eczema Refractory to Topical Potent Corticosteroids

    Nov 1, 2011, 00:00

  • PCV10 Un Estudio De Minimizacion De Costos Para Evaluar El Tratamiento Con Metoprolol En Pacientes Con Hipertension Arterial En México

    Nov 1, 2011, 00:00

  • PDB63 Anti-Diabetic Therapeutic Strategies for Type 2 Diabetes Patients with Chronic Kidney Disease in France

    Nov 1, 2011, 00:00

  • PIN67 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Negative Chronic Hepatitis B in Poland

    Nov 1, 2011, 00:00

  • PIH39 How Do Postmenopausal Women Describe Breast Pain and Breakthrough Bleeding Associated with Hormonal Treatments for Menopausal Symptoms- Qualitative Interviews with Postmenopausal Women in the United States, China, Mexico and Italy

    Nov 1, 2011, 00:00

  • PMD14 Budget Impact analysis of Two Drug-Eluting Stents for Diabetic Patients in Spain

    Nov 1, 2011, 00:00

  • PIN76 Cost Effectiveness analysis of Vaccination with 13-Valent (PCV13) and 23-Valent (PPV23) Pneumococcal Vaccines for Senior Adults in Brazil

    Nov 1, 2011, 00:00

  • PMD77 Components of Health Technology Assessment for Radiology in Chile

    Nov 1, 2011, 00:00

  • PMD68 Purchasing and Adopting Cardiovascular Devices- A Global Survey

    Nov 1, 2011, 00:00

  • PRS20 Costs of COPD By Disease Severity - a Comparison Over 10 Years

    Nov 1, 2011, 00:00

  • PND26 Estimated Costs of First-Year Monitoring and Administration of Multiple Sclerosis Therapies in the United States

    Nov 1, 2011, 00:00

  • PRM42 Valuation of HR-QoL Utilities by the EQ-5D in a Group of Chronically Ill Patients

    Nov 1, 2011, 00:00

  • PCN71 Value of Progression-Free Survival (PFS) in Refractory Non-Small Cell Lung Cancer (NSCLC)- An Exploratory Modeling Analysis

    Nov 1, 2011, 00:00

  • PRS70 Real World Evaluation of Different Smoking Cessation Service Models in England

    Nov 1, 2011, 00:00

  • PDB31 Cost of Diabetes in Croatia Impact of Complications on the Costs of Type II Diabetes

    Nov 1, 2011, 00:00

  • PCN21 Systematic Review of Skeletal Related Events in Prostate Cancer

    Nov 1, 2011, 00:00

  • VA2 Cost Effectiveness Analysis of Vaccination Programs With 10-Valent (PCV10) and 13-Valent (PCV13) Pneumococcal Vaccines in Bogotá, Colombia

    Nov 1, 2011, 00:00

  • PND66 Cross-Cultural Adaptation and Validation of the Brazilian Version of the Fatigue Severity Scale (FSS)

    Nov 1, 2011, 00:00

  • TP1 Prevalence of Lipid Abnormalities Before and After Introduction of Lipid Modifying Therapy Among Mexican Patients

    Nov 1, 2011, 00:00

  • PCN189 The Use of Parametric Survival Analysis to Predict Progression Free and Overall Survival of Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients

    Nov 1, 2011, 00:00

  • PGI21 Cost-Effectiveness of Peginterferon and Ribavirin for Elderly Patients with Chronic Hepatitis C- Results Based on the Nationwide Hepatitis Registration in Japan

    Nov 1, 2011, 00:00

  • PMH2 The Efficacy of the New Antidepressant Agomelatine as Compared Against Placebo and SSRIS- A Meta-Analysis Combining Published and Unpublished Data

    Nov 1, 2011, 00:00

  • PIN81 Cost-Effectiveness Analysis of Peg-Interferon Alpha-2A Plus Ribavirin Versus Conventional Interferon Alpha-2A Plus Ribavirin for the Treatment of Chronic Hepatitis C in China

    Nov 1, 2011, 00:00

  • PHP92 Lack of Clinical Efficacy as a Main Reason for Ahtapol Negative Recommendations for Orphan Oncology Drugs

    Nov 1, 2011, 00:00

  • RS4 The Interim Cancer Drugs Fund - How To Not Spend £50 Million

    Nov 1, 2011, 00:00

  • PCN161 The Lost Art of Needs Assessment- The Case of Hepatocellular Carcinoma (HCC) Control in European Countries

    Nov 1, 2011, 00:00

  • PHP17 Characteristics of High Cost Ambulatory Drugs in French Health Care System

    Nov 1, 2011, 00:00

  • PCV86 Long-Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome (ACS) from A Mexican Public and Private Health Care Perspective Based on Data from the Plato Trial

    Nov 1, 2011, 00:00

  • HG3 Cost Comparisons and Methodological Heterogeneity in Cost-of-Illness Studies- The Example of Colorectal Cancer

    Nov 1, 2011, 00:00

  • UT4 Comparison Of The Performance Of EQ-5D and SF-6D In Patients With Chronic Pain –Results From 3 Randomized Controlled Trials

    Nov 1, 2011, 00:00

  • PRS7 Estudio De Costo-Efectividad De Beclometasona vs Ciclesonida Como Medicamentos Controladores En El Manejo Del asma En Pacientes Que asisten A Consulta Externa De NeumologÍa Pediátrica En El Hospital Universitario Clínica San Rafael De ...

    Nov 1, 2011, 00:00

  • PCV46 Clinical and Economic Burden of Major Bleeding in Abdominal Surgery Patients

    Nov 1, 2011, 00:00

  • PRS71 Evaluation of the Getquit Clinics for Smoking Cessation

    Nov 1, 2011, 00:00

  • PRS77 Application of Innovative Methods to Identify and Characterize Differential Responders in Clinical Trials of COPD- The Use of Mixture Models

    Nov 1, 2011, 00:00

  • PND41 Predicting EQ-5D Utility Scores from the Huntington quality of Life instrument (H-QOL-I)

    Nov 1, 2011, 00:00

  • PMS27 Retrospective Chart Review to Assess Utilization of Resources and Costs Related to Postmenopausal Osteoporosis Treatment of Patients Without Fractures in Slovenia, Serbia, Slovakia and Bulgaria

    Nov 1, 2011, 00:00

  • PCV100 Resource Use in Patients with Acute Coronary Syndrome - an Observational Study Across Secondary and Primary Care in a UK Population

    Nov 1, 2011, 00:00

  • CN1 Mean Versus Median Overall Survival (OS) For Describing Value of New Cancer Therapies- A Case Study

    Nov 1, 2011, 00:00

  • PRM6 Translation of Patient-Reported Outcomes Measures Translatability Review And Item Definition

    Nov 1, 2011, 00:00

  • PSS28 Economic Burden of Advanced Melanoma- Findings From A Large US Health Insurance Database

    Nov 1, 2011, 00:00

  • PCV131 Cardiovascular Drug Utilization in Relation to Age in Nis Region

    Nov 1, 2011, 00:00

  • PCN56 Are Out-of-Pocket Payments for Oral Oncologic Therapies Too High? Updated Results From A U.S. Claims Data Analysis

    Nov 1, 2011, 00:00

  • PIN31 Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in Uganda

    Nov 1, 2011, 00:00

  • PSY57 Waist Circumference and Body Mass Index Recording – A Thin Database Study

    Nov 1, 2011, 00:00

  • PMS76 Treatment Patterns Among Patients with Shoulder Osteoarthistis

    Nov 1, 2011, 00:00

  • PRM51 Nonparametric Regression Analysis Controls Cost Analysis in Data with Outliers

    Nov 1, 2011, 00:00

  • PIN100 Why Don't Health Practitioners Prescribe Rationally in Malaria? A qualitative Study from Pakistan

    Nov 1, 2011, 00:00

  • PMH72 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length of Hospitalisation of Patients with Acute Bipolar Mania

    Nov 1, 2011, 00:00

  • PCN178 Reimbursement of Cancer Drugs in the UK- New Approach to End-of-Llife Treatments and the Technology Appraisal Programme of NICE

    Nov 1, 2011, 00:00

  • PMD37 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in France

    Nov 1, 2011, 00:00

  • PMH71 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length and Costs of Hospitalisation of Patients with Schizophrenia or Bipolar Disorder

    Nov 1, 2011, 00:00

  • PGI23 Economic Impact of Medication Adherence and Persistence in the Treatment of Ulcerative Colitis in Canada- Analyses with the Ramq Database

    Nov 1, 2011, 00:00

  • PCN152 Can Breast Cancer Risk Prediction Reduce the Risks of False Negative and False Positive Screening Mammograms?

    Nov 1, 2011, 00:00

  • PCV5 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with No Treatment Under the Brazilian Private Health Care System Per ...

    Nov 1, 2011, 00:00

  • PGI25 Chronic Hepatitis C (CHC) Related Flu-like Symptoms; Development of a Patient Report Outcome (PRO) Measure and Results from Pilot Efficacy Studies

    Nov 1, 2011, 00:00

  • PHP30 Biosimilars in the European Market

    Nov 1, 2011, 00:00

  • PIN23 To Assess or Not To Assess- That is the Question! Budget, Ethical and Decisional Impact assessment in HIV- Lombardy Region's Molo Project

    Nov 1, 2011, 00:00

  • PRS34 Cost-Effectiveness of Roflumilast (DAXAS®) in the Treatment Of Chronic Obstructive Pulmonary Disease (COPD) in Spain

    Nov 1, 2011, 00:00

  • PRM30 A Comparison of the Patientslikeme Quality of Life Questionnaire (PLMQOL) with the Rand SF-36

    Nov 1, 2011, 00:00

  • PHP56 The Emergent Role of the Specialist Pharmacist as an Important Stakeholder in Market Access

    Nov 1, 2011, 00:00

  • PDB47 Understanding the Implications of Incorporating the UKPDS Glycaemic Legacy Effect Into Evaluating the Cost-Effectiveness of Type 2 Diabetes Therapies

    Nov 1, 2011, 00:00

  • PIH57 Pediatric Daycare in Belgium

    Nov 1, 2011, 00:00

  • PRS60 The Impact of Severe Poor-Controlled Asthma On Patients' Quality of Life Control Study

    Nov 1, 2011, 00:00

  • PSY44 Association of the Obesity and Weight-Loss Quality-of-Life Score With Patient Demographics and Measures of Obesity

    Nov 1, 2011, 00:00

  • PND33 Cost Minimization Analysis of Fingolimod Compared to Natalizumab in Patients with Relapse Remitting Multiple Sclerosis in the Netherlands

    Nov 1, 2011, 00:00

  • PMH76 Patterns and Determinants of Sickness Absence Among Users of Antidepressants in a Danish Working Population

    Nov 1, 2011, 00:00

  • PGI2 Cost-Effectiveness Analysis of the Use of Adalimumab for the Treatment of Crohn's Disease (CD) in Mexico

    Nov 1, 2011, 00:00

  • PCV148 Multiple Propensity Score Analysis to Estimate Treatment Effects in Patients with Heart Failure

    Nov 1, 2011, 00:00

  • PHP8 ATC Classification and Its Role in Pricing Policies

    Nov 1, 2011, 00:00

  • PIN91 Sensitivity of Pro's in Evaluating Adverse Events in People Receiving Influenza Vaccination

    Nov 1, 2011, 00:00

  • PIN21 Clinico-Economic Evaluation of Treatment of Community-Acquired Pneumonia (CAP) Complicated by Sepsis with Moxifloxacin Compared to Ceftriaxone + Azithromycin

    Nov 1, 2011, 00:00

  • PSY7 Budget Impact Analysis of Bendamustine in the Treatment of Multiple Myeloma in Spain

    Nov 1, 2011, 00:00

  • PHP2 Relation Between Consumer Behaviour and Drug Safety Monitoring in France

    Nov 1, 2011, 00:00

  • PRM39 Identification of Diseases for EQ-5D Bolt-on Item Development- An Empirical Approach

    Nov 1, 2011, 00:00

  • PSS41 Impact on Quality of Patients With Active and Inactive Psoriasis in Spain

    Nov 1, 2011, 00:00

  • PCN147 Health-Related Quality of Life in Head and Neck Cancer Patients - Comparison with General Population Norms

    Nov 1, 2011, 00:00

  • PMS29 Abatacept or Infliximab for Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate- A Trial-Based and Real-Life Cost-Consequence Analysis

    Nov 1, 2011, 00:00

  • PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant Therapy

    Nov 1, 2011, 00:00

  • PHP17 Mexico'S National and Institutional Essential Medicine Lists

    Nov 1, 2011, 00:00

  • PSY3 Use Of A Discrete Event Simulation Model To Estimate Long Term Economic Outcomes Of Bariatric Surgery In Morbidly-Obese, Type-2 Diabetic Patients In Mexico

    Nov 1, 2011, 00:00

  • PCV6 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison With Enoxaparin Under the Brazilian Private Health Care System Persp ...

    Nov 1, 2011, 00:00

  • PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients with Overactive Bladder in the United Kingdom

    Nov 1, 2011, 00:00

  • PIH1 Comparison of Unintended Pregnancy Rates in Users of 84/7, 21/7, and 24/4 Oral Contraceptive Regimens

    Nov 1, 2011, 00:00

  • PHP93 Regional Differences among Methadone Maintenance Programs in Spain

    Nov 1, 2011, 00:00

  • PIH46 Satisfaction with Prescription and Over-the-Counter Medications- Results from a Novel Patient Registry

    Nov 1, 2011, 00:00

  • PCN89 Public Health Impact of Quadrivalent HPV Types 6, 11, 16, 18 Vaccine in Sao Paulo, Brazil Using A Transmission Dynamic Model

    Nov 1, 2011, 00:00

  • PCV19 Prescription of Angiotensin Converting Enzyme Inhibitors and Hypertension Control in Diabetic Hypertensive Patients

    Nov 1, 2011, 00:00
  • «
  • 131
  • 132
  • 133
  • 134 (current)
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • »